Clinical features of patients with RA included in the study
| Diagnosis | RA (n=18) |
|---|---|
| Age (years) | 58 (31–71) |
| The male to female ratio (n) | 5:13 |
| Disease duration (months) | 229 (1–413) |
| ESR (mm/h) | 31 (2–101) |
| CRP (mg/L) | 11.3 (1.0–128.9) |
| DAS28 | 4.06 (2.80–6.63) |
| ACPA+: n/total (%) | 11/18 (61) |
| RF+: n/total (%) | 10/18 (56) |
| Medications: n/total (%) | |
| NSAIDs | 8/18 (44) |
| Steroids | 4/18 (22) |
| DMARDs | 15/18 (83) |
| Biologicals | 10/18 (56) |
The values are expressed as median (range), unless otherwise indicated.
ACPA, anticitrullinated protein antibody; CRP, C reactive protein; DAS28, disease activity score in 28 joints based on ESR; DMARDs, disease-modifying antirheumatic drugs; ESR, erythrocyte sedimentation rate; NSAIDs, non-steroidal anti-inflammatory drugs; RA, rheumatoid arthritis; RF=rheumatoid factor.